In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Doxylamine succinate salt Drug Master File in Korea (Doxylamine succinate salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxylamine succinate salt. The MFDS reviews the Doxylamine succinate salt KDMF as part of the drug registration process and uses the information provided in the Doxylamine succinate salt KDMF to evaluate the safety and efficacy of the drug.
After submitting a Doxylamine succinate salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxylamine succinate salt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Doxylamine succinate salt suppliers with KDMF on PharmaCompass.